Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
02/08/2000 | US6022556 Swellable wound dressing materials |
02/08/2000 | US6022551 Rapidly disinfects surfaces including the hands; comprising alcohol, specific antimicrobial(s) such as benzethonium chloride, and cocophosphatidyl-dimonium chloride, and a copolymer carbomer thickener |
02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
02/03/2000 | WO2000005375A1 Gbs toxin receptor |
02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
02/03/2000 | WO2000005207A1 Substituted phenylamidines with antithrombotic action |
02/03/2000 | WO2000004954A2 Novel urokinase inhibitors |
02/03/2000 | WO2000004939A1 Dental pin |
02/03/2000 | WO2000004937A1 Flat flexible materials |
02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
02/03/2000 | WO2000004907A1 An antilipemic formulation |
02/03/2000 | WO2000004904A1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
02/03/2000 | WO2000004891A2 Anti-ulcer composition |
02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
02/03/2000 | WO2000004870A2 Composition for enhancing epidermal lipid production |
02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
02/03/2000 | WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
02/03/2000 | WO1999059620A9 Angiostatin receptor |
02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
02/03/2000 | DE19834819A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil |
02/03/2000 | DE19834816A1 Verwendung von Ectoin oder Ectoin-Derivaten in kosmetischen Formulierungen Use of ectoine or ectoine derivatives in cosmetic formulations |
02/03/2000 | DE19834814A1 Kosmetische und dermatologische Zubereitungen mit einem wirksamen Gehalt an Gallensäuren, ihren Salzen und/oder ihren Derivaten Cosmetic and dermatological preparations with an effective amount of bile acids, their salts and / or their derivatives |
02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
02/03/2000 | CA2338524A1 Inhibitors of urokinase and blood vessel formation |
02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
02/03/2000 | CA2337413A1 Substituted phenylamidines,pharmaceutical compositions containing these compounds and processes for preparing them |
02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
02/02/2000 | EP0975766A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
02/02/2000 | EP0975756A1 Fibroblasts with a foreign gene-containing composition for treating wounds |
02/02/2000 | EP0975739A1 Stimulation, culture and preservation of pancreatic and other cells |
02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
02/02/2000 | EP0975650A1 Oligomers which inhibit expression of collagen genes |
02/02/2000 | EP0975636A1 Novel compounds |
02/02/2000 | EP0975573A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
02/02/2000 | EP0975350A1 Use of an extract of alchemilli vulgaris |
02/02/2000 | EP0975325A1 Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof |
02/02/2000 | EP0975324A1 Anti-desquamative cosmetic composition and method for making said composition |
02/02/2000 | EP0975319A1 Skin care compositions containing an acid and a retinoid |
02/02/2000 | EP0975312A1 Compositions containing an antifungal and a phospholipid |
02/02/2000 | EP0975223A1 In-situ generation of zinc pyrithione |
02/02/2000 | EP0789686B1 Retinoylamide based derivatives of sphingoid bases |
02/02/2000 | CN1243507A Bis-sulfonomides hydroxamic acids as MMP inhibitors |
02/02/2000 | CN1243437A Use of dichlorobenzyl alchol for preparing a preparation for topical treatment of inflammation and preparation containing dichlorobenzyl alchol |
02/02/2000 | CN1243433A Personal cleansing compositions |
02/02/2000 | CN1243432A Personal cleansing compositions |
02/02/2000 | CN1243431A 皮肤制剂 Skin Product |
02/02/2000 | CN1243009A Preparation method for medicinal lotion |
02/02/2000 | CN1242997A Markless burn ointment |
02/02/2000 | CN1242992A Traditional Chinese medicine preparation for treating leuoderma |
02/02/2000 | CN1242984A 4,4-diaryl butadienes compound as water soluble non-photosensitive ultraviolet-ray filtering agent used in cosmetics and medicinal preparation |
02/01/2000 | US6020510 Cytoprotective compounds |
02/01/2000 | US6020363 Isocoumarin derivatives and use thereof in drugs |
02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
02/01/2000 | US6020340 Imidazopyridines |
02/01/2000 | US6020327 Control of hair growth |
02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
02/01/2000 | US6020320 Acyl deoxyribonucleoside derivatives and uses thereof |
02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
02/01/2000 | US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
02/01/2000 | CA2161191C Product containing a lipase and an active precursor for topical application |
01/27/2000 | WO2000004194A1 Gene sequence variances with utility in determining the treatment of disease |
01/27/2000 | WO2000004183A1 Bone morphogenic protein |
01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
01/27/2000 | WO2000003992A1 Quinoline derivatives |
01/27/2000 | WO2000003991A1 Quinoline derivatives |
01/27/2000 | WO2000003749A2 Method for regulating hair growth |
01/27/2000 | WO2000003748A2 Compositions which contain triterpenes for regulating hair growth |
01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
01/27/2000 | WO2000003723A1 Polymeric compounds and methods of formulating same |
01/27/2000 | WO2000003700A1 Compositions and methods of treating abnormal cell proliferation |
01/27/2000 | WO2000003689A2 Skin and tissue care and/or treatment agent |
01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
01/27/2000 | DE19831798A1 Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement |
01/27/2000 | CA2337883A1 Method for regulating hair growth |
01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
01/27/2000 | CA2337138A1 Compositions and methods of treating abnormal cell proliferation |
01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
01/27/2000 | CA2334075A1 Bone morphogenic protein |
01/26/2000 | EP0974586A1 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same |
01/26/2000 | EP0974342A1 Single phase transparent aqueous composition |
01/26/2000 | EP0974058A2 20 human secreted proteins |